Drug Profile
T-cell vaccine - ConserV Bioscience/SEEK
Alternative Names: Rotavirus vaccine - SEEK/ConserV BioscienceLatest Information Update: 30 Mar 2021
Price :
$50
*
At a glance
- Originator PepTcell
- Developer ConserV Bioscience
- Class Rotavirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Rotavirus infections
Most Recent Events
- 30 Mar 2021 ConserV Bioscience patent protection for its vaccine in World (ConserV Bioscience pipeline, March 2021).
- 30 Mar 2021 ConserV Bioscience patents pending for its vaccine in World (ConserV Bioscience pipeline, March 2021).
- 01 Jan 2021 Preclinical trials in Rotavirus infections in United Kingdom (Parenteral) before January 2021 (ConserV Bioscience pipeline, January 2021)